P2X7 receptor antagonism in the treatment of cancers

By Roger Séébastien   Pelegrin Pablo  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 875-880

Informa Healthcare

Access to resources Recommend Favorite

Chemoprevention of Cancers in Gastrointestinal Tract with Cyclooxygenase 2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 1, 2013-01 ,pp. : 115-125

Bentham Science Publishers

Access to resources Recommend Favorite

The P2X₇ receptor as a therapeutic target

By Romagnoli Romeo   Baraldi Pier Giovanni   Cruz-Lopez Olga   Lopez-Cara Carlota   Preti Delia   Borea Pier Andrea   Gessi Stefania  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 647-661

Informa Healthcare

Access to resources Recommend Favorite

Antagonism by the suramin analogue NF279 on human P2X 1 and P2X 7 receptors

By Klapperstuck M.   Buttner C.   Nickel P.   Schmalzing G.   Lambrecht G.   Markwardt F.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

Dissecting Individual Current Components of Co-expressed Human P2X1 and P2X7 Receptors

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 16, 2004-12 ,pp. : 1719-1730

Bentham Science Publishers

Access to resources Recommend Favorite